Stockscreener 앱 받기
1.32
2.94%
-0.04
전일 마감가:
$1.36
열려 있는:
$1.36
하루 거래량:
3,567
Relative Volume:
0.04
시가총액:
$3.19M
수익:
$5.31M
순이익/손실:
$-2.90M
주가수익비율:
-0.8886
EPS:
-1.4855
순현금흐름:
$-1.18M
1주 성능:
-14.29%
1개월 성능:
-34.98%
6개월 성능:
-49.17%
1년 성능:
-81.62%
1일 변동 폭
$1.2601
$1.36
1주일 범위
$1.2601
$1.5537
52주 변동 폭
$1.07
$7.21
Bionexus Gene Lab Corp Stock (BGLC) Company Profile
명칭
Bionexus Gene Lab Corp
전화
1-307-241-6898
주소
10-2 TOWER B, VERTICAL BUSINESS SUITE,, KUALA LUMPUR
Compare BGLC vs MOBBW, GOODO, PSNYW, SHMD, DWLD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BGLC
BioNexus Gene Lab Corp Common stock
|
0.343 | 201.51M | 0 | 0 | 0 | 0.00 |
MOBBW
Mobilicom Limited Warrants
|
1.64 | 2.64B | 0 | 0 | 0 | 0.00 |
GOODO
Gladstone Commercial Corporation
|
20.66 | 372.90M | 0 | 0 | 0 | 0.00 |
PSNYW
Polestar Automotive Holding Uk
|
2.48 | 375.29M | 2.07B | -1.42B | -1.37B | -0.6765 |
SHMD
Schmid Group N V
|
4.04 | 281.75M | 52.15M | -21.46M | 0 | -0.4675 |
DWLD
Davis Select Worldwide ETF
|
48.11 | 0 | 0 | 0 | 0 | 0.00 |
Bionexus Gene Lab Corp 주식(BGLC)의 최신 뉴스
BioNexus Says VitaGuard Blood Tests Could Cost Under $300 - Stock Titan
BGLC|BioNexus Gene Lab Corp|Price:1.370|Chg%:-0.140 - TradingKey
BGLC|BioNexus Gene Lab Corp|Price:1.450|Chg%:-0.060 - TradingKey
BioNexus Gene Lab Corp Revenue Breakdown – NASDAQ:BGLC - TradingView
BioNexus Gene Lab Corp (BGLC) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
BioNexus Gene Lab Corp (BGLC) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
BGLC|BioNexus Gene Lab Corp|Price:1.510|Chg%:-0.050 - TradingKey
BioNexus Gene Lab Corp (BGLC) Cash Flow - TradingKey
TradingKey - TradingKey
BioNexus Gene Lab Corp (BGLC) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
BioNexus Gene Lab Corp (BGLC) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
BioNexus Gene Lab Corp (BGLC) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
12 Industrials Stocks Moving In Thursday's Pre-Market SessionEos Energy Enterprises, Inc.Right (NAS - Benzinga
Price to sales forward of BioNexus Gene Lab Corp – NASDAQ:BGLC - TradingView
Enterprise value to revenue forward of BioNexus Gene Lab Corp – NASDAQ:BGLC - TradingView
Number of shareholders of BioNexus Gene Lab Corp – NASDAQ:BGLC - TradingView
BioNexus Gene Lab Corp (BGLC) Edges Higher as Shares Test Key ResistanceMoney Flow Index - dars.gov.et
Enterprise value to EBITDA forward of BioNexus Gene Lab Corp – NASDAQ:BGLC - TradingView
BioNexus Gene Lab Company Profile & Introduction - Moomoo
Price to earnings forward of BioNexus Gene Lab Corp – NASDAQ:BGLC - TradingView
Price to book forward of BioNexus Gene Lab Corp – NASDAQ:BGLC - TradingView
AI Investing InsightsOfficial HomepageIntellectia AI™ - Intellectia AI
BioNexus Gene Lab Corp (BGLC) Slips 6.95% as Shares Test Key Support LevelsGEX Level - Město Břeclav
BioNexus Gene Lab Corp (BGLC) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
BioNexus Gene Lab Corp (BGLC) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
BioNexus Gene Lab Corp (BGLC) Institutional Confidence - TradingKey
BioNexus Gene Lab Corp (BGLC) Valuation: PE, PB & Fair Value Analysis - TradingKey
BioNexus Gene Lab Corp (BGLC) Edges Higher as Shares Hold Above Key Support at $2.47Channel Breakout - newsline.com
BioNexus Gene Lab Corp (BGLC) Slips 4.1%: Testing Key Support at $2.09Elliott Wave Entry - newsline.com
BioNexus Gene Lab Calls for Malaysia–China Biotech Co-Development and Precision Healthcare Collaboration 1 - Minichart
BioNexus Gene Lab Urges Malaysia–China Co-Development of Biotech Platforms After Kuala Lumpur Forum - TradingView
BioNexus Gene Lab (Nasdaq: BGLC) pushes Malaysia–China biotech co-development model - Stock Titan
BioNexus Gene Lab Corp (BGLC) Slips 2.37% as Stock Tests Key Support AreaAscending Triangle - DonanımHaber
BioNexus Gene Lab Corp (BGLC) Declines 8.33% as Stock Approaches Key SupportHigh Beta Stocks - The Legal Advocate
BioNexus Gene Lab Corp (BGLC) Slides 4.17% as Support Level Nears – Key Levels to WatchRating Change - newsline.com
BioNexus Gene Lab Corp (BGLC) Slides 6.25%: Key Support Zone Under ScrutinyCash Flow Strong Stocks - The Legal Advocate
BioNexus Gene Lab Corp. Calls for Malaysia-China Biotechnology Collaboration Focused on Joint Development - geneonline.com
BioNexus Gene Lab Corp. Calls for Malaysia–China - GlobeNewswire
Turning Malaysia into a bridge for China’s biotech ambitions - Stock Titan
BGLCBioNexus Gene Lab Corp Stock Price and Quote - Finviz
BioNexus Gene Lab Stock Edges Up While Nasdaq Microcap Faces Chemrex Cash Battle - Bez Kabli
12 Industrials Stocks Moving In Wednesday's After-Market Session - Sahm
BioNexus Gene Lab Corp (BGLC) Surges 8.44%: Testing Key Resistance at $2.30Channel Breakout - The Legal Advocate
BioNexus Gene Lab (BGLC) Extends Decline, Tests Key Support at $1.92Crowd Entry Signals - Newser
BioNexus Gene Lab Corp 1Q 2026: Revenue $22.84K, EPS ($0.23) — 10-Q Summary - TradingView
BioNexus Gene Lab Corp. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
[10-Q] BioNexus Gene Lab Corp Quarterly Earnings Report - Stock Titan
BGLC | BioNexus Gene Lab Corp Insider Trading - Quiver Quantitative
Is BioNexus Lab (BGLC) stock fading in strength |Community Buy Alerts - newser.com
BioNexus Lab (BGLC) Risk Reward Ratio | BioNexus Gene Lab posts strong revenue, net lossCertified Trade Ideas - Xã Vĩnh Công
Bionexus Gene Lab Corp (BGLC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.73%
3.41%
자본화:
|
볼륨(24시간):